What happened to patients like the one in front of you?

Describe the patient, and see — in real time — how comparable rheumatoid arthritis patients in the Swedish Rheumatology Quality Registry (SRQ) were treated and how they responded within six months. A live, personalized registry pull at the point of care.

Matched cohort & outcomes

—

matching patients

—

reached low disease activity by 6 mo

—

reached remission by 6 mo

Treatment regimen	Patients ▼	↓ activity ≤6 mo	Remission ≤6 mo

↓ disease activity (DAS28-CRP <3.2)

remission (DAS28-CRP <2.6)

limited n fewer than 30 patients — interpret with caution

Demonstration only — synthetic data. This prototype illustrates what a live, personalized pull from the SRQ registry could look like for a clinician at the point of care. The ~80,000 patients, treatments and outcomes shown are computer-generated with clinically plausible but fabricated patterns. Nothing here reflects real patients or constitutes treatment guidance. Outcome definitions follow SRQ conventions (low disease activity DAS28<3.2, remission DAS28<2.6, assessed ~6 months after the treatment decision). Drug groups follow the registry's csDMARD / TNFi / non-TNFi bDMARD / tsDMARD (JAK-inhibitor) classification.